Ameliorative effect of thymoquinone on ovalbumin-induced allergic conjunctivitis in Balb/c mice

Current Eye Research

Volumn 36, Issue 7, 2011, Pages 591-598

  Hayat, Khizar ^a   Asim, Mb Raza ^a   Nawaz, Muhammad ^a   Li, Miao ^b   Zhang, Lin ^a   Sun, Naixue ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b City Hospital   (China)

Author keywords

Allergic conjunctivitis; Eosinophils; Histamine; Interleukins; Thymoquinone

Indexed keywords

DEXAMETHASONE; EOSIN; HEMATOXYLIN; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; OVALBUMIN; PHOSPHATE BUFFERED SALINE; THYMOQUINONE; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC CONJUNCTIVITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; EYE DISCHARGE; EYE SWELLING; GIEMSA STAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTAMINE BLOOD LEVEL; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BENZOQUINONES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONJUNCTIVITIS, ALLERGIC; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; HISTAMINE; IMMUNOGLOBULIN E; LEUKOCYTE COUNT; MICE; MICE, INBRED BALB C; OVALBUMIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79958724175     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.573898     Document Type: Article

References (31)

1. Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol. 2005;5:1749-1770. (Pubitemid 41594584)
2. Ragheb A, Attia A, Eldin WS, Elbarbry F, Gazarin S, Shoker A. The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent, against renal injury: A review. Saudi J Kidney Dis Transpl. 2009;20:741-752.
3. Kalus U, Pruss A, Bystron J, Jurecka M, Smekalova A, Lichius JJ, Kiesewetter H. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother Res. 2003;17:1209-1214. (Pubitemid 38057181)
4. Fukushima A, Ozaki A, Jian Z, Ishida W, Fukata K, Ueno H, Liu FT. Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice. Curr Eye Res. 2005;30:241-248. (Pubitemid 40806645)
5. Calder VL, Lackie PM. Basic science and pathophysiology of ocular allergy. Curr Allergy Asthma Rep. 2004;4:326-331. (Pubitemid 39359535)
6. Trocme SD, Sra KK. Spectrum of ocular allergy. Curr Opin Allergy Clin Immunol. 2002;2:423-427. (Pubitemid 35239525)
7. Proud D, Sweet J, Stein P, Settipane RA, Kagey-Sobotka A, Friedlaender MH, Lichtenstein LM. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol. 1990;85:896-905. (Pubitemid 20173127)
8. Fukagawa K, Nakajima T, Tsubota K, Shimmura S, Saito H, Hirai K. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol. 1999;103:1220-1221. (Pubitemid 29343097)
9. Leonardi A, Jose PJ, Zhan H, Calder VL. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology. 2003;110:487-492. (Pubitemid 36262729)
10. Leonardi A, Motterle L, Bortolotti M. Allergy and the eye. Clin Exp Immunol. 2008;153(Suppl. 1):17-21. (Pubitemid 352020378)
11. Epstein AB, Van Hoven PT, Kaufman A, Carr WW. Management of allergic conjunctivitis: An evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies. Clin Ophthalmol. 2009;3:329-336.
12. Ono SJ, Abelson MB. Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol. 2005;115:118-122. (Pubitemid 40075430)
13. Erdurmus M, Yagci R, Yilmaz B, Hepsen IF, Turkmen C, Aydin B, Karadag R. Inhibitory effects of topical thymoquinone on corneal neovascularization. Cornea 2007;26:715-719. (Pubitemid 47080292)
14. Chehl N, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA. Antiinflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford). 2009;11:373-381.
15. El Gazzar M, El Mezayen R, Marecki JC, Nicolls MR, Canastar A, Dreskin SC. Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int Immunopharmacol. 2006;6:1135-1142. (Pubitemid 43728167)
16. Vos AP, van Esch BC, Stahl B, MRabet L, Folkerts G, Nijkamp FP, Garssen J. Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice. Int Immunopharmacol. 2007;7:1582-1587. (Pubitemid 47505345)
17. Venza I, Visalli M, Ceci G, Teti D. Quantitative determination of histamine in tears during conjunctivitis by a novel HPLC method. Ophthalmic Res. 2004;36:62-69. (Pubitemid 38328012)
18. Shii D, Nakagawa S, Yoshimi M, Katsuta O, Oda T, Nakamura M. Inhibitory effects of cyclosporine a eye drops on symptoms in late phase and delayed-type reactions in allergic conjunctivitis models. Biol Pharm Bull. 2010;33:1314-1318.
19. Friedlaender MH. Conjunctivitis of allergic origin: Clinical presentation and differential diagnosis. Surv Ophthalmol. 1993;38(Suppl.):105-114. (Pubitemid 23239417)
20. Ozaki A, Seki Y, Fukushima A, Kubo M. The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model. J Immunol 2005;175:5489-5497. (Pubitemid 41456436)
21. Kari O, Salo OP, Bjorksten F, Backman A. Allergic conjunctivitis, total and specific IgE in the tear fluid. Acta Ophthalmol (Copenh). 1985;63:97-99. (Pubitemid 15133739)
22. el-Asrar AM, Tabbara KF, Geboes K, Missotten L, Desmet V. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis. Am J Ophthalmol. 1996;121:156-161. (Pubitemid 26055159)
23. Mimura T, Usui T, Mori M, Funatsu H, Noma H, Yamamoto H, Aixinjueluo W, Amano S. Relationship between total tear and serum IgE in allergic conjunctivitis. Int Arch Allergy Immunol. 2010;154:349-352.
24. Ballow M, Mendelson L. Specific immunoglobulin E antibodies in tear secretions of patients with vernal conjunctivitis. J Allergy Clin Immunol. 1980;66:112-118. (Pubitemid 10087510)
25. Knol EF. Requirements for effective IgE cross-linking on mast cells and basophils. Mol Nutr Food Res. 2006;50:620-624. (Pubitemid 44105968)
26. Abelson MB, Torkildsen GL, Williams JI, Gow JA, Gomes PJ, McNamara TR. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single- center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children. Clin Ther. 2009;31:1908-1921.
27. Bielory L, Friedlaender MH. Allergic conjunctivitis. Immunol Allergy Clin North Am. 2008;28:43-58, vi. (Pubitemid 351241107)
28. Bielory L, Lien KW, Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs. 2005;65:215-228. (Pubitemid 40139383)
29. Leonardi A, Motterle L, Bortolotti M. Allergy and the eye. Clin Exp Immunol. 2008;153(Suppl. 1):17-21. (Pubitemid 352020378)
30. Yamashita S, Yamashita T, Yamada K, Tachibana H. Flavones suppress type I IL-4 receptor signaling by down-regulating the expression of common gamma chain. FEBS Lett. 2010;584:775-779.
31. Kato H, Kohata K, Yamamoto J, Ichikawa S, Watanabe M, Ishizawa K, Ichinohasama R, Harigae H. Extreme eosinophilia caused by interleukin-5- producing disseminated colon cancer. Int J Hematol. 2010;91:328-330.